Chronic hepatitis C successfully treated with telaprevir, Pegylated interferon and ribavirin in severe aplastic anemia

Annals of Hepatology

Volumn 13, Issue 6, 2014, Pages 843-844

  Balkan, Ilker I ^a   Bozcan, Selma ^a   Yemisen, Mucahit ^a   Kutlubay, Zekayi ^a   Ozaras, Resat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PEGINTERFERON ALPHA2A; RIBAVIRIN; STEROID; TELAPREVIR; VIRUS RNA; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; OLIGOPEPTIDE; RECOMBINANT PROTEIN;

ADULT; APLASTIC ANEMIA; CASE REPORT; CYTOPENIA; DRUG DOSE REDUCTION; ERYTHROCYTE TRANSFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; LIVER BIOPSY; MALE; NEUTROPENIA; PARAPSORIASIS; SEBORRHEIC DERMATITIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; YOUNG ADULT; ANEMIA, APLASTIC; COMPLICATION; HEPATITIS C, CHRONIC;

ANEMIA, APLASTIC; ANTIVIRAL AGENTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN; YOUNG ADULT;

EID: 84908671241     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)30990-1     Document Type: Letter

References (8)

1. Zeuzem S, Andreone P, Pol S, Lawitz E, Diago M, Roberts S, Focaccia R, et al. REALIZE Study Team. Telaprevir for retreatment of HCV infection. N Engl J Med 2011; 364: 2417-28.
2. Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, et al. ADVANCE Study Team. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011; 364(25): 2405-16.
3. McHutchison JG, Manns MP, Muir AJ, Terrault NA, Jacobson IM, Afdhal NH, Heathcote EJ, et al. PROVE3 Study Team. Telaprevir for previously treated chronic HCV infection. N Engl J Med 2010; 362(14): 1292-303.
4. Belperio PS, Hwang EW, Thomas IC, Mole LA, Cheung RC, Backus LI. Early virologic responses and hematologic safety of directacting antiviral therapies in veterans with chronic hepatitis C. Clin Gastroenterol Hepatol 2013; 11(8): 1021-7.
5. Strasser SI, Myerson D, Spurgeon CL, Sullivan KM, Storer B, Schoch HG, Kim S, et al. Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10year follow-up. Hepatology 1999; 29(6): 1893-9.
6. Ljungman P, Locasciulli A, de Soria VG, Békássy AN, Brinch L, Espigado I, Ferrant A, et al. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Long-term follow-up of HCVinfected hematopoietic SCT patients and effects of antiviral therapy. Bone Marrow Transplant 2012; 47: 1217-21.
7. American Association for the Study of Liver Diseases and Infectious Diseases Society of America. Recommendations for testing, managing, and treating hepatitis C. Retrieved from: http://www.hcvguidelines.org/full-report-view 2014.
8. Mutimer D, Aghemo A, Diepolder H, Negro F, Robaeys G, Ryder S, Zoulim F, et al. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. European Association for Study of Liver. J Hepatol 2014; 60: 392-420.